<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01878084</url>
  </required_header>
  <id_info>
    <org_study_id>BIOGLASS-STDF#116</org_study_id>
    <nct_id>NCT01878084</nct_id>
  </id_info>
  <brief_title>Bioactive Glass (Sol-gel) for Alveolar Bone Regeneration After Surgical Extraction</brief_title>
  <official_title>Phase I/II Trial of Alveolar Bone Engineering Using Bioactive Glass (Sol-Gel) Immediately After Premolar Extraction in Patients Requiring Orthodontic Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lehigh University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present research is to evaluate the effect of bioactive glass in bone
      regeneration immediately following extraction of mandibular and maxillary premolars.The
      hypothesis of the study assumes that this treatment would promote the healing of the
      extraction socket while preserving both the height and width of the bone. Furthermore, it
      would allow more effective tooth movement during orthodontic treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bioactive glass has long been known as a bone graft substitute capable of bone augmentation.
      The current proposal introduces a newly tailored bioactive glass scaffold with multi-scale
      porosity prepared using the sol-gel technique to regenerate bone in extraction sockets with
      the aim of preserving the alveolar ridge. This novel material has the potential to enhance
      angiogenesis and osteogenesis thereby preserving the overall height and width of the alveolar
      bone by regenerating new bone that closely mimics the adjacent healthy one. Thirty patients
      requiring myofunctional therapy including premolar extraction as part of a two stage
      orthodontic treatment (class II division I) will be enrolled in this phase I/II clinical
      study. Patients will undergo extraction of their maxillary and mandibular premolar teeth.
      This will serve as a split-mouth study where on one side the extraction sockets will be left
      empty while on the other side they will receive the bioactive glass as a bone graft
      substitute. Clinical and radiographic assessment of healing will be performed at the
      following time intervals; 1,2,4,12,24 weeks. Clinical criteria will include scoring for pain,
      inflammation, and occurrence of any post-operative complications using a well-defined scoring
      system. Radiographic assessment will monitor the changes in crestal bone height and bone
      mineral density. Computed tomographic scans will also be taken preoperatively and at 6 months
      for each patient for 3D assessment of bone changes. A core biopsy will also be taken after
      informed consent at the 6 months time-point to evaluate the quality and quantity of new bone
      formed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This study represents a split-mouth study where the right or left/ upper or lower premolar could be assigned to either the control group (socket left empty) or test group (socket filled with bioactive glass (sol-gel)
The extraction sockets will be allocated either to the control : Extraction socket will be left empty
or
Test: Extraction socket will be augmented using bioactive glass (sol-gel)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Alveolar Crestal Bone Height</measure>
    <time_frame>assessed at baseline, 1,2,4,8,12,24 weeks post-extraction, baseline,4 and 12 weeks reported.</time_frame>
    <description>The primary objective of the study is to determine the effect of using bioactive glass in preservation of alveolar crestal height and width surgical sockets immediately after premolar extraction assessed at baseline, 1,2,4,8,12,24 weeks post-extraction, baseline ,4 and 12 weeks reported. This change was analyzed by subtracting the values of each interval from the baseline values.the positive values indicate that the alveolar crest is coronal to the cemento enaml junction (reference point) , while the negative values indicate that the alveolar crest in apical to the cemento enamel junction (reference point)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone Mineral Density</measure>
    <time_frame>assessed at baseline, 1,2,4,8,12,24 weeks post-extraction, baseline,4 and 12 weeks reported.</time_frame>
    <description>The primary objective of the study is to determine the effect of using bioactive glass in inducing alveolar bone regeneration safely and effectively in surgical sockets immediately after premolar extraction assessed at baseline, 1,2,4,8,12,24 weeks post-extraction, baseline,4 and 12 weeks reported.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Bone Loss</condition>
  <condition>Vertical Alveolar Bone Loss</condition>
  <condition>Horizontal Alveolar Bone Loss</condition>
  <arm_group>
    <arm_group_label>all study participants</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This study represents a split-mouth study where the right or left/ upper or lower premolar could be assigned to either the control group (socket left empty) or test group (socket filled with bioactive glass (sol-gel)
The extraction sockets will be allocated either to the control : Extraction socket will be left empty
or
Test: Extraction socket will be augmented using bioactive glass (sol-gel)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>bioactive glass (sol-gel)</intervention_name>
    <description>Extraction sockets will be augmented using bioactive glass (sol-gel)</description>
    <arm_group_label>all study participants</arm_group_label>
    <other_name>Tailored Amorphous Multiscale Porous (TAMP) scaffold</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>empty extraction socket</intervention_name>
    <description>Extraction socket will be left empty</description>
    <arm_group_label>all study participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must have good oral hygiene (confirmed by OHI-S)

          -  Patients who had voluntarily agreed on signing an informed consent including the
             duration and all the steps of the trial

          -  Patients who are indicated for the administration of the type of local anesthesia used
             in the trial

          -  Patients who need myofunctional therapy including premolar extraction as part of two
             stage treatment (class II division I)

          -  Patients indicated for premolar extraction as a normal step in the treatment plan not
             intentionally for the experiment.

          -  Patients who had undergone x- rays on the premolar teeth showing root form and the
             shape of the socket prior to extraction

        Exclusion Criteria:

          -  Patients with history of bleeding disorders which will hinder the normal healing
             process of the needed sockets for the trial

          -  Patients with history of allergy to foreign bodies , i.e. susceptible to reactions
             from Bioglass

          -  Patients with history of hypertension and diabetes , rendering them not indicated for
             administration of the recommended type of local anesthesia nor even for extraction

          -  Patients having HCV , HBV , HIV or other infectious diseases to make sure of the
             safety of the research team and the participants from probable infection .

          -  Mentally retarded patients who are not able to understand the steps of the trial
             Patients with systemic diseases or febrile illness making them unable to follow the
             appointments arranged

          -  Patients who simultaneously participate in other research studies

          -  Patients with traumatic surgical extraction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mona Marei, prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alexandria University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tissue Engineering Laboratories, Faculty of Dentistry, Alexandria University</name>
      <address>
        <city>Alexandria</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 10, 2013</study_first_submitted>
  <study_first_submitted_qc>June 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2013</study_first_posted>
  <results_first_submitted>January 18, 2017</results_first_submitted>
  <results_first_submitted_qc>February 10, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 18, 2020</results_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Prof. Mona K. Marei</investigator_full_name>
    <investigator_title>professor/head of tissue engineering laboratories, faculty of dentistry</investigator_title>
  </responsible_party>
  <keyword>Tissue regeneration</keyword>
  <keyword>sol gel bioglass</keyword>
  <keyword>alveolar ridge preservation</keyword>
  <keyword>children</keyword>
  <keyword>Egyptian</keyword>
  <keyword>class II orthodontic cases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alveolar Bone Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>participants were recruited from the outpatient clinic of the orthodontic department at the Faculty of Dentistry of Alexandria University From October 2013 to October 2014</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>All Study Participants</title>
          <description>Bone regeneration utilizing tissue engineering principles and approach via using porous bioactive glass prepared by sol gel technique to properly fill the empty socket after tooth extraction. The target is to preserve the buccal and lingual alveolar plates of the socket regarding width and height, to avoid bone resorption and to stimulate bone regeneration. This novel technique will be evaluated via histological (biopsy), radiographic, and bone density measurements in addition to clinical assessment.
This study represents a split-mouth study where the right or left/ upper or lower premolar could be assigned to either the control group (socket left empty) or test group (socket filled with bioactive glass (sol-gel)
The extraction sockets will be allocated either to the control : Extraction socket will be left empty
or
Test: Extraction socket will be augmented using bioactive glass (sol-gel)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Test(Received TAMP Bioglass) s</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Control (Sockets Were Left Empty)</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This is a split mouth study design, and so each patient serves as both test and control.</population>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>Bone regeneration utilizing tissue engineering principles and approach via using porous bioactive glass prepared by sol gel technique to properly fill the empty socket after tooth extraction. The target is to preserve the buccal and lingual alveolar plates of the socket regarding width and height, to avoid bone resorption and to stimulate bone regeneration. This novel technique will be evaluated via histological (biopsy), radiographic, and bone density measurements in addition to clinical assessment.
This study represents a split-mouth study where the right or left/ upper or lower premolar could be assigned to either the control group (socket left empty) or test group (socket filled with bioactive glass (sol-gel)
The extraction sockets will be allocated either to the control : Extraction socket will be left empty
or
Test: Extraction socket will be augmented using bioactive glass (sol-gel)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12" spread="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Egyptians</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Egypt</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Alveolar Crestal Bone Height</title>
        <description>The primary objective of the study is to determine the effect of using bioactive glass in preservation of alveolar crestal height and width surgical sockets immediately after premolar extraction assessed at baseline, 1,2,4,8,12,24 weeks post-extraction, baseline ,4 and 12 weeks reported. This change was analyzed by subtracting the values of each interval from the baseline values.the positive values indicate that the alveolar crest is coronal to the cemento enaml junction (reference point) , while the negative values indicate that the alveolar crest in apical to the cemento enamel junction (reference point)</description>
        <time_frame>assessed at baseline, 1,2,4,8,12,24 weeks post-extraction, baseline,4 and 12 weeks reported.</time_frame>
        <population>previously described</population>
        <group_list>
          <group group_id="O1">
            <title>All Study Participants</title>
            <description>This study represented a split-mouth study where the right or left/ upper or lower premolar was assigned to either the control group (socket left empty) or test group (socket filled with bioactive glass (sol-gel)
The extraction sockets were allocated either to the control : Extraction socket were left empty
or
Test: Extraction socket were augmented using bioactive glass (sol-gel
bioactive glass (sol-gel): Extraction sockets were augmented using bioactive glass (sol-gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Alveolar Crestal Bone Height</title>
          <description>The primary objective of the study is to determine the effect of using bioactive glass in preservation of alveolar crestal height and width surgical sockets immediately after premolar extraction assessed at baseline, 1,2,4,8,12,24 weeks post-extraction, baseline ,4 and 12 weeks reported. This change was analyzed by subtracting the values of each interval from the baseline values.the positive values indicate that the alveolar crest is coronal to the cemento enaml junction (reference point) , while the negative values indicate that the alveolar crest in apical to the cemento enamel junction (reference point)</description>
          <population>previously described</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>extraction sockets</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>extraction sockets</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline control mesial alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.32" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>baseline test mesial alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.84" spread="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>baseline control distal alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.59" spread="1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>baseline test distal alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.96" spread="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks control mesial alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks test mesial alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="1.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks control distal alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" spread="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks test distal alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="1.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks control mesial alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.13" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks test mesial alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="1.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks control distal alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks test distal alveolar bone height value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.47" spread="0.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Bone Mineral Density</title>
        <description>The primary objective of the study is to determine the effect of using bioactive glass in inducing alveolar bone regeneration safely and effectively in surgical sockets immediately after premolar extraction assessed at baseline, 1,2,4,8,12,24 weeks post-extraction, baseline,4 and 12 weeks reported.</description>
        <time_frame>assessed at baseline, 1,2,4,8,12,24 weeks post-extraction, baseline,4 and 12 weeks reported.</time_frame>
        <population>previously described</population>
        <group_list>
          <group group_id="O1">
            <title>All Study Participants</title>
            <description>This study represented a split-mouth study where the right or left/ upper or lower premolar were assigned to either the control group (socket left empty) or test group (socket filled with bioactive glass (sol-gel)
The extraction sockets were allocated either to the control : Extraction socket were left empty
or
Test: Extraction socket were augmented using bioactive glass (sol-gel</description>
          </group>
        </group_list>
        <measure>
          <title>Bone Mineral Density</title>
          <description>The primary objective of the study is to determine the effect of using bioactive glass in inducing alveolar bone regeneration safely and effectively in surgical sockets immediately after premolar extraction assessed at baseline, 1,2,4,8,12,24 weeks post-extraction, baseline,4 and 12 weeks reported.</description>
          <population>previously described</population>
          <units>percentage of BMD</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>extraction sockets</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>extraction sockets</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline control coronal bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.30" spread="14.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>baseline test coronal bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.28" spread="19.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>baseline control middle bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.32" spread="16.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>baseline test middle bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.92" spread="17.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>baseline control apical bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.17" spread="13.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>baseline test apical bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.61" spread="16.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks control coronal bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.54" spread="17.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks test coronal bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.03" spread="14.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks control middle bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.29" spread="18.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks test middle bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.95" spread="16.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks control apical bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.47" spread="14.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks test apical bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.98" spread="13.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks control coronal bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.71" spread="14.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks test coronal bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.44" spread="13.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks control middle bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.59" spread="15.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks test middle bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.14" spread="11.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks control apical bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.10" spread="12.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks test apical bone density value</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.15" spread="13.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>All-Cause Mortality, Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed; Since the material used has been previously tested for other bone applications and no adverse events were reported.</desc>
      <group_list>
        <group group_id="E1">
          <title>All Study Participants</title>
          <description>This study represented a split-mouth study where the right or left/ upper or lower premolar were assigned to either the control group (socket left empty) or test group (socket filled with bioactive glass (sol-gel)
The extraction sockets were allocated either to the control : Extraction socket were left empty
or
Test: Extraction socket were augmented using bioactive glass (sol-gel)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Mona K. Marei</name_or_title>
      <organization>Alexandria University</organization>
      <phone>002-03-4858353</phone>
      <email>mona.marei@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

